Skip to main content

Table 3 Characteristics of the RTT patient and control brain samples used in this study.

From: Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain

Sample

Source

UId

Sex

Age

Mutation

     

nt change

aa change

domain affected

type of mutation

RTT1

HBTRC

4315

F

11

c.763C>T

R255X

TRD-NLS

Nonsense

RTT3

HBTRC

4422

F

12

c.808C>T

R270X

TRD-NLS

Nonsense

RTT4

TICHR

NB

F

18

c.473C>T

T158M

MBD

Missense

RTT5

TICHR

KB

F

11

c.316C>T

R106W

MBD

Missense

RTT6

TICHR

BC

F

21

c.808C>T

R270X

TRD-NLS

Nonsense

RTT9

BCM

93-244

F

4

c.750insC

P251fs

TRD

Frameshift/Truncation

CON4

NSWTRC

88210

F

43

    

CON5

NSWTRC

88295

F

42

    

CON6

NSWTRC

88365

F

31

    

CON7

NSWTRC

88304

F

43

    

CON8

NSWTRC

9092

F

46

    

CON10

NSWTRC

12862

F

52

    
  1. Abbreviations: HBTRC = The Harvard Brain Tissue Resource Center, Boston, USA; NSWTRC = The New South Wales Tissue Resource Centre, Sydney, Australia; BCM = Baylor College of Medicine, Houston, USA; TICHR = Telethon Institute for Child Health Research, Perth, Australia; UId = unique identifier from original source; MBD = methyl-binding domain; TRD = transcription repression domain; NLS = nuclear localization signal.